GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Orthofix Medical Inc (NAS:OFIX) » Definitions » Gross Margin %

Orthofix Medical (Orthofix Medical) Gross Margin %

: 68.17% (As of Dec. 2023)
View and export this data going back to 1992. Start your Free Trial

Gross Margin % is calculated as gross profit divided by its revenue. Orthofix Medical's Gross Profit for the three months ended in Dec. 2023 was $136.6 Mil. Orthofix Medical's Revenue for the three months ended in Dec. 2023 was $200.4 Mil. Therefore, Orthofix Medical's Gross Margin % for the quarter that ended in Dec. 2023 was 68.17%.

Warning Sign:

Orthofix Medical Inc gross margin has been in long-term decline. The average rate of decline per year is -3.2%.


The historical rank and industry rank for Orthofix Medical's Gross Margin % or its related term are showing as below:

OFIX' s Gross Margin % Range Over the Past 10 Years
Min: 65.13   Med: 76.77   Max: 78.67
Current: 65.13


During the past 13 years, the highest Gross Margin % of Orthofix Medical was 78.67%. The lowest was 65.13%. And the median was 76.77%.

OFIX's Gross Margin % is ranked better than
70.23% of 796 companies
in the Medical Devices & Instruments industry
Industry Median: 53.54 vs OFIX: 65.13

Orthofix Medical had a gross margin of 68.17% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Orthofix Medical was -3.20% per year.


Orthofix Medical Gross Margin % Historical Data

The historical data trend for Orthofix Medical's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orthofix Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 78.13 74.94 75.26 73.18 65.13

Orthofix Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.96 62.97 63.93 65.09 68.17

Competitive Comparison

For the Medical Devices subindustry, Orthofix Medical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orthofix Medical Gross Margin % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Orthofix Medical's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Orthofix Medical's Gross Margin % falls into.



Orthofix Medical Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Orthofix Medical's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=486.3 / 746.641
=(Revenue - Cost of Goods Sold) / Revenue
=(746.641 - 260.368) / 746.641
=65.13 %

Orthofix Medical's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=136.6 / 200.415
=(Revenue - Cost of Goods Sold) / Revenue
=(200.415 - 63.785) / 200.415
=68.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Orthofix Medical  (NAS:OFIX) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Orthofix Medical had a gross margin of 68.17% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Orthofix Medical Gross Margin % Related Terms

Thank you for viewing the detailed overview of Orthofix Medical's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Orthofix Medical (Orthofix Medical) Business Description

Traded in Other Exchanges
Address
3451 Plano Parkway, Lewisville, TX, USA, 75056
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
Executives
James F. Hinrichs director 3750 TORREY VIEW COURT, SAN DIEGO CA 92130
Puja Leekha officer: CECO & Interim CLO 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Geoffrey C Gillespie officer: VP, Controller, Interim CFO 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Kevin J. Kenny officer: President of Global Spine C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
Shweta Maniar director C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Stuart Essig director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
John J. Bostjancic officer: CFO C/O SEASPINE HOLDINGS CORPORATION, 2302 LA MIRADA DRIVE, VISTA CA 92081
Keith Valentine director, officer: President & CEO 7475 LUSK BLVD., SAN DIEGO CA 92121
Henneman John B Iii director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Patrick L Keran officer: Chief Legal Officer 6725 MESA RIDGE RD., SUITE 100, SAN DIEGO CA 92121
Thomas A. West director C/O INTERSECT, INC., 1555 ADAMS DRIVE, MENLO PARK CA 94025
Michael E Paolucci director 7475 LUSK BLVD., SAN DIEGO CA 92121
Catherine M Burzik director
Rice Doug officer: CFO 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Kimberley A. Elting officer: Chief Legal Officer 3451 PLANO PARKWAY, LEWISVILLE TX 75056

Orthofix Medical (Orthofix Medical) Headlines

From GuruFocus